The following is a summary of “Impaired LTB4-induced neutrophil chemotactic directionality in myelodysplastic neoplasms ...
Myelodysplastic syndrome (MDS) comprises a group of clonal bone marrow disorders characterized by ineffective hematopoiesis and increased predisposition to acute myeloid leukemia. The causes of ...
Emergency hemopoiesis may maintain blood counts and a proinflammatory environment in MDS, AML, and ICUS. Altered neutrophil subset distributions in MDS and AML show diagnostic sensitivity, with ...
Patients with myelodysplastic syndromes (MDS) who undergo allogeneic hematopoietic stem cell transplantation (allo-HSCT) are older and face worse outcomes compared with non-MDS patients ...
Only one blood cell type may be abnormal, or more than one. DNA mutations can be present.
The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or ...
Geron could have a tougher time than it anticipated at tomorrow’s FDA advisory committee meeting for myelodysplastic syndromes (MDS ... points to a high risk of neutropenia and thrombocytopenia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback